Tuesday, December 05, 2017 11:28:43 AM
NOTICE IS HEREBY GIVEN that the Annual General Meeting of the shareholders (the “Meeting”) of Nymox Pharmaceutical Corporation (the “Corporation”) will be held at the British Colonial Hilton, Nassau Bahamas, Number One Bay St., Nassau Bahamas, on Tuesday, December 19, 2017, at 4:30 p.m. (EDT), for the following purposes:
1.
to receive the annual report of the directors, the financial statements of the Corporation for the fiscal year ended December 31, 2016 and the auditors' report thereon;
2.
to elect the directors of the Corporation;
3.
to appoint the auditors of the Corporation and to authorize the Board of Directors to fix their remuneration;
4.
to ratify the acts of the members of the Board of Directors for the fiscal year ending 2016; and, up and to the date of this meeting;
5.
to transact such other matters as may properly be brought before the Meeting, or any adjournment thereof.
All shareholders are invited to attend the Meeting.
By order of the Board of Directors,
Paul Averback MD CEO & President
November 28, 2017 Nassau, The Bahamas
Recent NYMXF News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/18/2024 07:36:48 PM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM